Arthrosurface Inc. received FDA 501(k) clearance for its BOSS toe fixation system, which is intended to improve stabilization in a first metatarsal with a distal bone void.

“Finally, there is an option other than fusion for failed synthetic implants. We can preserve motion of the joint, even in these difficult cases where there is a defect or void in the bone,” Carl Hasselman, MD, an orthopedic surgeon with UPMC in Pennsylvania, said in a company press release.